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The bacterial endotoxin receptor TLR4 is subject to multiple points of regulation at the level of 
signalling, biogenesis and trafficking. Dysregulation of the pathway can cause serious 
autoimmune diseases such as sepsis. Here we report that the p24/emp family protein TMED7 
controls the trafficking of TLR4 from the Golgi to the cell surface. TMED7 is able to form a 
stable complex with the ectodomain of TLR4, an interaction that requires the coiled-coil and 
GOLD domains but not the cytosolic COP II sorting motif of TMED7. Depletion of TMED7 
reduced MyD88 but not TRAM/TRIF dependent signaling through the TLR4 pathway. 
Truncated forms of TMED7 that lack the COP II sorting motif or transmembrane domain are 
mislocalized and can cause constitutive activation of the TLR4 signalling pathways. Overall 
these results support the hypothesis that p24 proteins act as a quality control step by recognising 
correctly folded anterograde cargo in the early secretory compartments and positively regulate 
the translocation of cargo such as TLR4 to the cell surface.  
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INTRODUCTION 
The Toll-like receptor 4 (TLR4) is a key regulator of innate immunity and inflammation. It is 
activated by the complex and heterogenous glycolipid lipolysaccharide (LPS) present in the outer 
membrane of Gram –ve bacteria (1). Although TLR4 is a key element of host defence against 
Gram -ve pathogens, dysregulation of this signal transduction pathway causes endotoxic shock, a 
severe condition that leads to multi-organ failure and death. Because of its importance in innate 
immunity and disease the activity of TLR4 is highly regulated not only by positive and negative 
effectors of the signal transduction pathway but also at the level of biosynthesis and trafficking.  
TLR4 functions at the cell surface and also signals from early endosomes (2, 3). The 
trafficking events that accompany activation of TLR4 are fairly well understood. Stimulation of 
TLR4 by LPS induces internalization of the receptor into early endosomes, a process that 
requires the accessory protein CD14, the GTPase Rab and potentially signalling by the Syk 
tyrosine kinase (4-6). TLR4 is unusual as it promotes two signalling pathways via MyD88 
leading to activation of NF-κB and proinflammatory responses and through the TRAM and TRIF 
adaptors to the activation of interferon response factors (IRF3 and 7) (7). The evidence suggests 
that the latter pathway is only active after internalization. By contrast the trafficking processes 
that accompany biosynthesis are less well characterized. Two chaperone molecules gp96 and 
PRAT4 are required for proper processing of TLR4 in the ER that leads to the secretion of the 
receptor to the plasma membrane (8-10). Association of TLR4 with MD2 in the ER is also 
crucial for correct glycosylation, secretion to the plasma membrane, and hence LPS 
responsiveness (11-14). The involvement of other components of the secretory pathway, 
especially those related to vesicular trafficking, is however relatively unknown. A recent study 
has shown that Rab10 is responsible for transporting TLR4 from the Golgi to the plasma 
membrane upon LPS stimulation (15).  
Secretion of cell surface transmembrane proteins is initiated by translocation and folding 
of the protein in the ER. Proteins destined for secretion rather than ER residence are then 
selectively packaged into vesicles for transport to the cis-Golgi. This process is dependent on the 
ability of the cargo protein to recruit COP II coat protein complexes that leads to their assembly 
around the budding membrane prior to vesicle formation (16). This recruitment is mediated by 
the presence of COP II-binding motif of di-phenylalanine in the cytosolic tail of the cargo 
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protein (17-19). However soluble cargo proteins and indeed many transmembrane proteins 
including TLR4 do not have this cytosolic diphenylalanine signal. Instead these cargo molecules 
are selected by transmembrane adaptor proteins that have recognition domains exposed in the ER 
lumen and short cytoplasmic tails that include the diphenylalanine sorting motif for COP II and a 
dibasic signal for COP I dependent retrograde transport back to the ER from the Golgi (20).  
One important family of transmembrane adaptor proteins are the p24 proteins, 
alternatively called TMED (transmembrane emp24 protein transport domain containing) in 
vertebrates. There are ten family members in mammals and they are very highly conserved 
across species. TMEDs consist of luminal golgi dynamics (GOLD) and coiled coil domains in 
the lumen, a single transmembrane spanning region and a short cytosolic tail with COP II and/ or 
COP I sorting signals (21, 22). TMEDs form homo and hetero dimers and are found in the early 
secretory pathway of the ER, ER golgi intermediate compartment (ERGIC), the cis-Golgi, and 
COP I and II-coated vesicles (19, 23-26). In yeast, deletion of several p24 proteins leads to 
defects in secretion of several proteins and in formation of secretory vesicles, and activation of 
the unfolded protein response (UPR), but is not lethal (27-29). In mouse, deletion of certain 
TMEDs leads to defective embryogenesis that can be lethal (30, 31). Although it is clear that 
TMEDs have a fundamental cell biological function in the selection of secretory cargo little is 
known about the nature of the cargo molecules or the molecular mechanisms by which these 
molecules are recognized in the ER and dissociated in the Golgi (22).  
In this paper we show that the pattern recognition receptor TLR4 is a cargo molecule for 
TMED7 which tightly regulates trafficking of the receptor to the cell surface. Dysregulation of 
TMED7- mediated transport leads to potentially dangerous constitutive activation of the TLR4 
signalling pathway. 
 
RESULTS 
TMED7 is a type I membrane protein with a luminal N-terminal Golgi Dynamics (GOLD) 
domain. 
Previous reports have suggested that TMED7 is localized on the cytosolic surface of the 
membrane (32). However those studies contradict bioinformatic analysis that predicts TMED7 to 
be a secreted membrane protein with a type I topology, and a short cytosolic domain at the C-
terminus (Figs. 1A, C, S1A, and B). In order to resolve this issue we asked whether TMED7 
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contains N-linked glycans and disulphide bonds, post-translational modifications that are added 
to the protein in the lumen of the endoplasmic reticulum during biosynthesis. Treatment of cell 
extracts with the glycosidase PNGaseF leads to the formation of a faster migrating species of 
TMED7-FLAG (Fig. 1B). This shows that TMED7 is glycosylated most likely at asparagine 103 
in the GOLD domain, the only predicted N-linked glycosylation site found in the protein with the 
consensus sequence of Asn-Xaa-Thr, which is absolutely conserved in TMED7 across various 
species (Fig. S1C). A similar outcome was seen in TLR4, which is heavily glycosylated, but not 
in TRAM which is not glycosylated (Fig. S2A). This finding confirms the observation made by 
Fullekrug (24). Multiple sequence alignment of p24 proteins reveals that there are two absolutely 
conserved cysteine residues within the GOLD domain that may be involved in the formation of a 
disulphide bridge (21). To test this hypothesis, we expressed TMED7-HA in HEK293T cells and 
analyzed the protein under reducing and non-reducing conditions. Under non-reducing 
conditions TMED7 migrates faster, a characteristic of the oxidized denatured state (Fig. 1B). 
Finally, recombinant human TMED7 proteins with its native or fusion signal peptide (SP-CC and 
PP-CC, respectively) were expressed in insect cells and analyzed by Edman degradation which 
revealed that a hydrophobic N-terminal signal sequence had been cleaved before residue serine 
35 (19, Fig. S2B and C). Taken together this evidence supports the membrane topology for 
TMED7 shown in Fig 1C. 
 
TMED7 oligomers interact with TLR4 in the Golgi  
We next asked whether TMED7 is able to dimerize or oligomerize with itself and interact with 
TLR4. Three truncated constructs of TMED7 were generated with C-terminal HA or FLAG tag 
(Fig. 2A) and transfected into HEK293T cells. FLAG-tagged protein was immunoprecipitated 
and anti HA antibody was used to detect any HA-tagged protein that formed complexes. 
TMED7, Delta, and CC can form an oligomer between themselves and each other, but not 
GOLD (Figs. 2B and D). This shows that the coiled-coil domain, which is lacking in the GOLD 
construct, is required for oligomerization. Fusion proteins expressed in THP-1 macrophages by 
lentiviral transduction also showed that TMED7 was able to oligomerize with itself and that it 
requires the coiled-coil domain for function (Fig. S3A).  
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To test whether TLR4 interacts with TMED7 and the truncation mutants, HEK293T cells 
were transfected with FLAG-TLR4, CD14, MD2, and TRAM-FLAG (TLR4 complex) along 
with HA-tagged TMED7 or its truncated mutants. FLAG-tagged protein was 
immunoprecipitated and anti-HA antibody was used to detect associated protein. We found that 
TMED7, Delta, and CC were co-immunoprecipitated with the TLR4 complex but the construct 
lacking the coiled-coil motif (GOLD) was not (Fig. 2C and D). TLR3, however, did not interact 
with TMED7 (Fig. S3B). Treatment with 100 ng/ml LPS reduced the amount of full length 
TMED7 but not CC bound to TLR4 (Fig. 2C).  This suggests that LPS stimulation might trigger 
the dissociation of TLR4 from TMED7.  
Confocal microscopy analysis using unstimulated HEK293T cells revealed that the 
interaction between TLR4 and TMED7 occurred in the Giantin-positive intracellular 
compartment, which is an organelle marker for the Golgi (Fig. 3). In transduced THP-1 
macrophages TLR3 did not co-localize with TMED7 in the Golgi, which suggests that TMED7 
may recognize TLR4 specifically (Fig. S6A). Together, these data indicate that the coiled-coil 
domain of TMED7 mediates homo- or hetero- dimerization and that TLR4 binds to dimeric 
TMED7 in the Golgi in the unstimulated state. 
 
TMED7 modulates TLR4 signalling  
The results above suggest that TMED7 recognizes TLR4 in the ER as cargo for transport to the 
Golgi. We therefore asked whether depletion of TMED7 affected LPS induced signalling by 
TLR4. TMED7 transcript is expressed in both HEK293 cells and the THP-1 macrophages (Fig 
4A). Transfection of HEK293 cells and THP-1 macrophages with gene-specific siRNAs resulted 
in a substantial reduction in gene expression of TMED7 but a scrambled control siRNA had no 
effect (Fig 4B). Depletion of TMED7 with siRNA reduced IL-6 and TNFα production, but not 
RANTES, in THP-1 macrophages stimulated with LPS (Fig. 4C). Luciferase reporter assays 
performed in transfected HEK293 cells showed that TMED7 knockdown by siRNA reduced NF-
κB but not IFNβ activation upon TLR4 stimulation by LPS providing further evidence that only 
the MyD88-dependent pathway is affected by TMED7 knockdown (Fig. S4A and B). By 
contrast depletion of TMED7 did not affect TLR3 and TLR5 signalling induced by Poly I:C and 
flagellin, respectively (Fig. S4C and D).  
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We also performed the reciprocal assay by over-expressing TMED7 to see whether 
signalling was enhanced. As the amount of TMED7 transfected into HEK293 cells was 
increased, the basal signalling level in the absence of LPS increased for both MyD88 and 
TRIF/TRAM pathways. By contrast LPS induced signalling was unaffected by the 
overexpression (Fig. 5B and C). This shows that TMED7 acted upstream of TLR4 activation by 
LPS. The responses seen in this assay were specific for LPS induced TLR4. GOLD 
overexpression did not cause similar increase in TLR4 constitutive activity. Thus this effect is 
not caused by the transfection of foreign DNA plasmid (Fig. S5A and B). Moreover, both NF-κB 
and IFNβ luciferase activity is dependent on the presence of all TLR4 signalling components 
(Fig. S5C, D, and E). Lastly, TMED7, Delta, and CC did not alter the activity of TLR3 and 5 
upon their stimulation in transiently transfected HEK293 cells (Fig. S5G and H). Altogether, this 
suggests that TMED7 can promote ligand-independent activation of TLR4 signalling. To explore 
this finding further, we determined which components of the TLR4 receptor complex are 
required to interact with TMED7. Co-immunoprecipitation experiments show that TLR4 on its 
own or in combination with co-receptors CD14 and MD-2 can interact with TMED7. Although 
the TLR4 adaptor TRAM is not able to associate with TMED7, it substantially enhances TMED7 
binding to the TLR4 complex and TLR4 alone (Fig. 5A, lane 3, 4, 7, 8, and 9). 
 
Regulatory roles of the cytoplasmic tail and transmembrane domain of TMED7 in TLR4 
signalling 
Previous studies have shown that COP-I and II binding motifs in the cytoplasmic tail, as well as 
the conserved E and Q residues in the transmembrane domain of p24 proteins determine the 
direction of trafficking and the rate of recycling of the proteins within the early secretory 
pathway (17, 19, 33). We therefore investigated whether these would affect TLR4 signalling. To 
study this, we used the truncated mutants described above (Fig. 2A). Expression of delta mutant 
increased constitutive signalling through the MyD88 and TRIF/TRAM pathways by about 20-
fold but a residual level of LPS-inducible signalling was also detected (Fig. 6A and B). The 
effect seen here was greater than that of full length TMED7 (compare to Fig. 5B and C). CC 
expression also enhanced constitutive activity of both pathways to a similar level to that of full 
length TMED7 (Fig. 6C and D), whereas GOLD overexpression did not have any effect, as 
expected since this truncation does not interact with TLR4 (Fig. S5A and B).  
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Roles of the cytoplasmic tail and transmembrane domain of TMED7 in its intracellular 
localization 
Next we wanted to address the link between TMED7’s role in the intracellular trafficking of 
TLR4 and its signalling activity. First, we confirmed the intracellular localization of TMED7 
shown by previous studies (19, 24-26) and determined whether the COP II sorting motif is 
required for this localization. THP-1 macrophages were transduced with the full length and 
truncated TMED7 constructs and the localization of these and the Golgi marker Giantin were 
visualized by immunofluorescent microscopy. As previously reported full length TMED7 is 
predominantly present in the Golgi as it co-localizes tightly with giantin (Fig. 7A).  By contrast 
the Delta, CC, and GOLD truncations are not concentrated in the Golgi but are instead widely 
dispersed in the cytoplasm (Fig. 7B, C, and D). A similar pattern was observed in HEK293T 
cells transfected with C-terminally FLAG-tagged TMED7 or its truncated mutants (Fig. S7A). 
Further analysis in HEK293T cells using anti-protein disulphide isomerase (PDI), a marker for 
the ER, showed that while both CC and GOLD seem to overlap with PDI, Delta is distributed 
more diffusely and does not accumulate in the Golgi (Fig. S7B). Therefore it is evident that the 
cytosolic tail of TMED7 is essential for its correct localization within the Golgi as loss of the 
diphenylalanine motif causes the protein to be trapped in the endomembrane system.  
 
TMED7 facilitates cell surface expression of TLR4 
LPS stimulation of TLR4 can be initiated from either cell surface or in the Golgi following LPS 
internalization (34, 35). Therefore the cell surface expression level could determine the extent of 
LPS responsiveness observed above. N-glycosylation of TLR4 is important for cell surface 
expression and responsiveness to the ligand. Studies have shown that chaperone molecules are 
important for this process, as well as MD2, which is required for the glycosylation of TLR4 that 
enables the cell surface expression (9, 12, 36). 
To assess the role of TMED7 in trafficking of TLR4 to the cell surface we used flow 
cytometry analysis performed on transfected HEK293T cells expressing FLAG-TLR4 and MD2, 
as well as on THP-1 macrophages expressing endogenous TLR4. Since the FLAG tag was 
located in the N-terminal of TLR4 ectodomain and the cells were not fixed nor permeabilized, 
only TLR4 molecules on the surface of HEK293T cells were observed in the assay. Viable cells 
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were gated based on forward and side scatter profile and this population was then analyzed for 
cells positive for Alexa Fluor 488 signal (TLR4) with the isotype control set as the signal 
threshold. Untransfected and unstained cells were included as negative controls to ensure that the 
signals were not due to non-specific antibody binding and auto-fluorescent cells, respectively. 
We used this method to measure the cell surface expression of TLR4 when the endogenous 
TMED7 level was knocked down with specific siRNA and when the protein was overexpressed. 
As shown in Fig. 8A, overexpression of transfected TMED7 leads to an increase in surface 
localized TLR4 receptors. By contrast knock-down of TMED7 in HEK293T cells led to a 
substantial reduction in the level of cell surface TLR4 based on percentage of transfected cells 
expressing cell surface TLR4 (Fig. 8B). These findings were validated by repeating the knock-
down experiment in THP-1 macrophages. Knock-down of TMED7 caused a decrease in 
endogenous cell surface TLR4 and this was not due to decrease in gene expression of TLR4 (Fig. 
8C and D).  
Taken together these results indicate that TMED7 is involved in early stage trafficking of 
TLR4 leading to its transport to the cell surface and therefore positively regulates the signalling 
activity of the receptor.  
 
DISCUSSION 
In this paper we show that TLR4 is a cargo molecule for TMED7 a Golgi dynamics protein that 
facilitates the intracellular trafficking of the receptor prior to its transport to the cell surface. We 
present several lines of evidence that TMED7 is a type I membrane protein with a luminal N-
terminal and a short cytoplasmic domain with characteristic di-phenylalanine COP II sorting 
motif (Fig. 1A and C). This topology for TMED7 (also called (g)p27 or p24γ3) is supported by 
historical studies, including N-terminal sequencing of native TMED7 isolated from Golgi 
membrane fractions of rat which reveals a cleaved signal peptide (19). Our conclusions are not, 
however, consistent with a recent study which reports that TMED7 is anchored in the membrane 
by the N-terminal helix and the GOLD domain is exposed to the cytoplasm (32). This conclusion 
was drawn from membrane fractionation assays by mutating each of the helical regions 
individually and protease protection assays although the experiment presented lacks a positive 
control to show that a bona fide ER lumen protein is protected from degradation under the 
conditions used. Doyle et al. also conclude that TMED7 interacts directly with the signalling 
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adaptor TRAM and a TMED7-TRAM splice hybrid (TRAM with GOLD domain (TAG)) (37), 
acting as negative regulator of the TLR4 signalling from the endosome. By contrast in this study 
we cannot detect a direct interaction between TMED7 and TRAM in unstimulated cells, a result 
that is consistent with the membrane topology and function we propose. In the case of TAG, a 
splicing product that includes the GOLD and coiled-coil domains of TMED7 joined to the TIR 
domain of TRAM, it may be that it is secreted and has a dominant negative effect by forming 
heterodimers with endogenous TMED7 in the ER lumen.  
We have shown that the luminal coiled-coil and GOLD domains of TMED7 are sufficient 
to mediate binding of TLR4 and therefore it is likely the ectodomain of TLR4 that mediates 
binding. The GOLD domain alone does not form dimers and cannot bind to TLR4 suggesting 
that recognition requires homodimerization of TMED7 or heterodimerization with other TMED 
family members. It also establishes, as expected, that the domain predicted to form a α-helical 
coiled-coil mediates dimerization. The Delta and CC mutants which lack both the anterograde 
sorting signal for COP II also bind to TLR4 but do not accumulate in the Golgi. Thus it is likely 
that trafficking of TLR4 to the Golgi requires segregation into COP II coated vesicles by TMED 
homo-or hetero dimers and that association of TMED7 and TLR4 in a stable complex defines 
receptors that are transiting the early secretory pathway.  
The presence of TRAM causes a substantial enhancement of TMED7 binding to TLR4. 
This could indicate that TRAM becomes pre-associated with TLR4 TIR domain during 
biosynthesis and this inhibits recognition of the COP II sorting motif and anterograde trafficking, 
leading to an accumulation of TMED7/TLR4 in the ER. In this regard previous studies show that 
TLR4 and TRAM co-localize in the Golgi and at the cell surface suggesting coordinated 
trafficking of the receptor and adaptor (38). TRAM is modified by the addition of the fatty acid 
myristate to an N-terminal glycine residue. The myristoyl group is added by the enzyme N-
myristoyl transferase and the modified proteins are co-translationally inserted into the ER 
membrane (39). Thus another explanation for the observed accumulation of TMED7/TLR4 
complexes might be that overexpression of TRAM sterically blocks the formation of the COP II 
coats required for anterograde transport, again causing the down regulation of ER to Golgi 
transport.  
The expression of the Delta form of TMED7 enhances constitutive signalling to both 
IFNβ and NF-κB activation by about 20 fold suggesting that proper regulation of early stage 
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secretion is necessary to repress ligand-independent signalling that would produce potentially 
dangerous inflammatory responses. Lower levels of constitutive activation of about 2-5 fold are 
also observed when the wild type TMED7 and CC mutant are overexpressed, but not the GOLD 
domain alone. Constitutive activation of TLR4 can occur when the receptors accumulate in 
membranes to high concentrations. The TLR4 ectodomain acts as a constitutive suppressor of 
TLR4 activation and this repression can be relieved by exposure to ligand, overexpression, 
truncation or substitution with domains having a propensity for dimerization (40). In the case of 
CC the constitutive signal may originate from intracellular compartments as trafficking via the 
Golgi appears to be blocked, leading to accumulation of TLR4 intracellularly. On the other hand 
the activity caused by overexpressed full length TMED7 is probably the result of enhanced 
secretion of TLR4 to the cell surface (Fig. 8). Delta enhances signalling with and without the 
LPS which suggests that intracellular accumulation of TLR4 can drive an LPS-independent 
activation. Overall these results demonstrate a role for the di-phenylalanine COP II sorting motif 
in the cytosolic tail, and glutamic acid and glutamine residues in the transmembrane domain of 
TMED7 in TLR4 trafficking (17, 19, 33). These studies show that the interactions between these 
key residues not only affect the localization but also the rate of the anterograde trafficking of the 
TMED protein in a regulated manner (33).  
It is interesting to note that while the overexpression of TMED7 affected both MyD88 
and TRAM-dependent pathways, the knockdown only affected the MyD88-dependent pathway 
of TLR4 signalling. It is possible that this selectivity is caused by the fact that these two 
pathways are initiated from two distinct locations—the cell surface and early endosomes (2, 5). 
Kagan et al. proposed the sequential initiation of MyD88-dependent pathway on the cell surface 
followed by endocytosis and initiation of TRAM-dependent pathway in the early endosomes. 
The model put forward by Husebye et al. showed that there are two distinct TLR4 populations on 
the cell surface and in the endocytic recycling compartment (ERC) of human monocytes that can 
respond to E. coli infection independently of each other. From these conclusions, we can 
postulate that whilst initiation of MyD88-dependent pathway upon TLR4 stimulation relies on 
the transport of the receptor to the cell surface, the activation of TRAM-dependent pathway 
relies on both the endocytosis of activated receptor and the trafficking of naive TLR4 in the ERC 
to the ligand-containing phagosome which is Rab11a-dependent. Therefore, the main role of 
TMED7 is to traffick TLR4 to the cell surface and not to the other intracellular compartments 
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such as the ERC. This explains why TMED7 depletion only affects the MyD88-dependent 
pathway from the cell surface.  
Little is known about the molecular mechanisms by which TMED proteins associate with 
their cargoes in the ER. However the available evidence suggests that secretion is coupled to the 
addition of N-linked glycans in the ER. For example a systematic mutagenesis of potential N-
glycosylation sites in TLR2 showed that all four are modified and contribute to efficient 
secretion, although a conserved site at the C-terminus is of particular importance (41). In the case 
of TLR4 there are nine N-glycans and two of these, N526 and N575, are essential for secretion 
with other sites having a more partial effect on cell surface expression (12). Thus an attractive 
hypothesis is that TMED7, acting as a quality control step, assembles with TLR4 by recognising 
the nascent glycosylated receptor in the ER lumen and marking the receptor as cargo for 
anterograde transport in COP II vesicles to ERGIC and Golgi compartments.  
Another aspect of interest is the release mechanism of TLR4 from TMED7 in the Golgi. 
Recently Rab10 was identified to promote TLR4 trafficking to the cell surface from the Golgi 
(15). It is therefore possible that TMED7 and Rab10 work together in the process of TLR4 
transport to the cell surface. However, the precise molecular events that lead to this have not 
been elucidated yet. The acidic pH of the compartment in the late secretory pathway could lead 
to the dissociation between TMED and its cargo protein (42), a similar general mechanism also 
operates to cause release of LDL from its receptor after internalization into acidic endosomes 
(43). A more tightly regulated switch could be implemented such as that used by TMED2 in the 
resensitization of protease-activated receptor (PAR) 2 on the cell surface from the Golgi (44). In 
the resting state, TMED2 associates with its PAR2 cargo in the Golgi. Upon stimulation of 
PAR2 on the cell surface, the receptors are endocytosed and the cell surface has to be 
replenished with new populations of the receptor. This event is mediated by the activation of a 
small GTP-binding protein ADP-ribosylation factor (ARF) 1 that leads to the dissociation of 
PAR2 from TMED2. This could explain the decrease in the amount of TMED7 associated with 
the TLR4 upon LPS stimulation in HEK293T cells (Fig. 2C). Perhaps a similar mechanism is 
employed in this particular system to resensitize the TLR4 receptors.  
In future studies we aim to explore the nature of the interactions between TMED dimers 
and TLR ectodomain glycans at a molecular level and test the hypothesis that disassembly of 
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TLR4 in the Golgi is mediated by the transition to low pH and Golgi specific modification of the 
glycans. 
 
MATERIALS AND METHODS 
Constructs, and antibodies 
Human TLR4 and human CD14 in pcDNA3, human MD2 in pEFIRES, and p125 -luc were 
generously provided by Dr Clare Bryant, University of Cambridge, UK. p125-luc contains the 
promoter region of IFN-β followed by firefly luciferase as described previously (45). phRG-TK 
and pNF-κB-luc were purchased from Promega and Clontech respectively. TRAM with C-
terminal FLAG and His tags (TRAM-FLAG) in pEF-BOS, TLR4 with N-terminal FLAG tag 
(FLAG-TLR4) were gifts from Dr Ashley Mansell, MIMR, Australia. TMED7-GFP in EX-
V1709-M03 (OmicsLink) was a gift from Prof. Luke O’Neill, Trinity College Dublin, Ireland. 
pHR: TLR4Cit and pHR: TLR3Cit with C-terminal mCitirine tag were gifts from Dr Brett 
Verstak.  
Primary antibodies used in this study were anti-HA produced in rabbit and in chicken 
(abcam, ab9110 and ab9111 respectively), anti-FLAG produced in mouse (Sigma, F3165), IgG1 
isotype control from murine myeloma (Sigma, M5284),  anti-giantin produced in rabbit (abcam, 
ab24586), anti-PDI antibody [RL77]-ER marker produced in mouse (abcam, ab5484), anti-
human CD284 (TLR4) PE (eBioscience, 12-9917), and mouse IgG2a Κ isotype control PE 
(eBioscience, 12-4724) . Secondary antibodies used in this study were anti-rabbit IgG (whole 
molecule)-peroxidase produced in goat (Sigma, A0545), anti-mouse IgG (whole molecule)-
peroxidase produced in goat (Sigma, A4416), Mouse TrueBlot ULTRA: anti-mouse Ig HRP 
(eBioscience, 18-8817) for Western blotting. For immunofluorescence, Alexa Fluor 633 goat 
anti-chicken IgG (H+L) (Molecular Probes, A21103), and Alexa Fluor 405 goat anti-rabbit IgG 
(H+L) (Molecular Probes, A31556), and Alexa Fluor 488 goat anti-mouse IgG (H+L) 
(Molecular Probes, A11001). 
 
 
 
Cloning and mutagenesis 
 15 
Mammalian expression vectors of human TMED7 and its truncated mutants were constructed 
using TMED7-GFP in EX-V1709-M03 as the template using Gateway cloning technology 
(Invitrogen). Standard PCR reactions were performed using Vent polymerase (NEB). The 
constructs created were called TMED7 (full length, 1-224), CC (1-187), and GOLD (1-144). 
attB1 and attB2 sites were incorporated into the forward and reverse primers respectively, 
flanking the gene, for cloning into the pDONR221 entry vector by Gateway BP reaction using 
BP clonase enzyme. One forward primer contained an attB1 site followed by the native signal 
peptide of TMED7 in 5′-3′ direction. Three reverse primers, for each of the three constructs, 
consisted of an attB2 site, stop codon, FLAG or HA tag, and followed by TMED7 gene specific 
sequence in 5′-3′ direction.  Gateway LR reaction was then performed using LR clonase enzyme 
to insert the gene into a Gateway pcDNA-DEST47 destination vector ready for expression in 
mammalian cells. 
Another mutant of TMED7, Delta (1-210, lacking the cytoplasmic tail) with C-terminal 
HA, was created by Quikchange mutagenesis using PfuTurbo (Stratagene). Primer pairs for 
mutagenesis were designed to skip the cytoplasmic tail to be deleted, using TMED7-HA 
previously made as a template in the PCR reaction. See Supplementary Materials for primer 
sequences (Tables S1 and 2).  
For lentivirus production, genes of interest were cloned into pHR vector. Briefly, PCR 
reactions were carried out to amplify the genes of interest and to incorporate a BamH1 and a 
Not1 restriction sites at the 5′ and 3′ ends of the gene respectively. Both the PCR products and 
pHR:TLR4Cit were treated with BamH1 and Not1 restriction enzymes (NEB, R3136 and 
R3189) according to the manufacturer’s protocol and purified. Ligation reactions were carried 
out using T4 DNA Ligase (NEB, M202). See Supplementary Materials for protocol for lentivirus 
production. 
 
Cell culture and DNA transfection 
HEK293 and HEK293T cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Sigma, D5546). The media was supplemented with 2 mM L-glutamine, 100 units/ml penicillin, 
100 µg/ml streptomycin, and 10% (v/v) heat-inactivated foetal calf serum (FCS) at 37°C, 5% 
CO2. jetPEI transfection reagent (Polyplus transfection) was used for DNA plasmid transfection 
according to the manufacturer’s protocol. A total of 100 ng of DNA plasmid was transfected per 
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well in a 96-well plate. For cells grown on a 6-well plate, a total of 3 µg of DNA plasmid were 
transfected per well. For detailed accounts of the amount of DNA transfected for different 
assays, see Tables S3-5. Cells were analyzed 24-48 hours post-transfection. 
THP-1 monocyte was from Dr Clare Bryant. The cells were maintained in suspension in 
RPMI-1640 with L-glutamine and sodium bicarbonate (Sigma, R8758), supplemented with 10% 
FCS, 100 units/ml penicillin, 100 µg/ml streptomycin, 25 mM HEPES, and 20 μM β-
mercaptoethanol. Prior to siRNA transfection, THP-1 monocytes had to be differentiated into 
THP-1 macrophages. For differentiation, cells were treated with 100 ng/ml phorbol myristate 
acetate (PMA) (Sigma, P8139) in complete RPMI for two days prior to subsequent analysis.  
 
siRNA transfection, RNA extraction, and qPCR 
siRNA duplexes targeting TMED7 were purchased from Invitrogen (Stealth siRNA HSS121495, 
or siRNA95 for short) and from Sigma (siRNA2 and 3). siRNA2 and 3 duplexes were designed 
in our lab using siRNA target finder tool from Ambion. Generated sequences were subsequently 
ranked using parameters described in (46) and only two sequences with the highest scores were 
selected, see Table S6 for sequences of the siRNA duplexes. siRNA transfection into HEK293/ 
293T cells was performed using jetPRIME transfection reagent (Polyplus transfection) per well 
and incubated for three days prior to consequent DNA transfection or data collection. siRNA 
transfection into THP-1 macrophages was performed using INTERFERin (Polyplus transfection) 
two days after PMA treatment, and cells were incubated for three more days prior to subsequent 
analyses by ELISA or flow cytometry. 
Total RNA from cells were purified using RNeasy Plus kit and QiaShredder (QIAgen). 
First strand cDNA was synthesized from the total RNA using SuperScript II reverse transcriptase 
(Invitrogen) with random hexamer (Promega, C1181) as described in the protocol from 
Untegasser lab (http://www.untergasser.de/lab/protocols/cdna_synthesis_superscript_ii_v1 
_0.htm).  
The cDNA served as template for real time quantitative PCR (qPCR) analysis to 
determine the level of gene knockdown using Platinum SYBR Green qPCR SuperMix 
(Invitrogen, 11733038). Relative gene level of TMED7 was determined and normalized against 
internal control of GAPDH (for HEK293T) or β-Actin (for THP-1 macrophages) to determine 
the relative gene knockdown using Livak method of 2
(-ΔΔCt)
. The gene-specific primers for 
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TMED7, TRAM, TLR4, β-Actin, and GAPDH were designed to span the exon-exon junction to 
eliminate amplification of genomic DNA (Table S7).  
 
Luciferase reporter assay 
The protocol was adapted from a previously described method (47). Briefly, HEK293 cells were 
transfected with appropriate expression vectors using jetPEI transfection reagent. Reporter genes 
used were p125-luc and pNF-κB-luc. For knockdown experiment, siRNA was transfected three 
days prior to DNA transfection as described above. 48 hours after the DNA transfection, cells 
were stimulated with LPS from E. coli O127:B8 (Sigma Aldrich, L3129), Poly I:C HMW 
(Inivogen, tlrl-pic), or flagellin from S. typhimurium (Invivogen, tlrl-stfla) diluted in serum-free 
DMEM for 6 hours. The cells were washed in PBS and then lysed using passive lysis buffer 
(Promega) diluted in PBS. Firefly and Renilla luciferase activities were quantified individually 
using luciferin and coelenterazine reagents respectively using LUMIstar Omega luminometer 
(BMG Labtech). 
 
Enzyme-linked immunosorbent assay 
Three days post siRNA transfection into THP-1 macrophages, the cells were stimulated with 
LPS diluted in serum-free RPMI-1640 for 24 hours at concentrations indicated in the figures. 
The amount of human IL-6, TNFα, and RANTES cytokines produced upon LPS stimulation was 
measured in the culture supernatant following the protocol from R&D systems ELISA kit.  
 
Co-immunoprecipitation and Western blot analysis 
48-72 hours following transfection or transduction, cells were lysed in cold lysis buffer (50 mM 
Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA,  2 mM MgCl2, 2 mM CaCl2) containing 1% 
Triton X-100, 0.5% n-Octylglucoside, and supplemented with 1 mM PMSF and 1x protease 
inhibitor cocktail set V (Calbiochem, 535141). Soluble extract of cell lysate was collected by 
centrifugation at 15000 g for 10 min. FLAG-tagged recombinant proteins in the rest of the 
supernatant were immunoprecipitated by incubation with anti-FLAG M2 magnetic beads 
(Sigma, M8823, using DynaMag-2 magnet (Invitrogen) to separate beads from wash buffer. 
Total protein and co-immunoprecipitated samples were analyzed by Western blot using 
antibodies as indicated in figures.  
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Enzymatic deglycosylation  
Protein was harvested from HEK293T cells in lysis buffer as described above, but with 1% NP-
40 detergent only. TMED7-HA from cell lysate was treated with 1000 U PNGaseF (NEB) 
following the manufacturer’s protocol, or just the buffers for negative control for overnight at 
37°C. SDS loading buffer with reducing agent was added to the beads and boiled at 100°C for 10 
min. Samples were analyzed by Western blot.  
 
Confocal microscopy 
Cells were seeded on coverslips on a 6-well plate. Two-three days after transfection or 
transduction, the media was aspirated off from the wells, and cells on the coverslips were washed 
once in cold phosphate buffer saline (PBS). The cells were then fixed using 4% 
paraformaldehyde in PBS and permeabilized with 0.2% Triton x-100 in PBS at room 
temperature. Cells were washed twice between steps in cold PBS. For immunohistostaining, cells 
were blocked in blocking buffer (5% BSA in PBS with 0.1% Tween-20 (PBST)) for 30 min at 
room temperature. Cells were stained in a cocktail of primary antibodies against HA produced in 
chicken and Giantin produced in rabbit (all diluted 1:200 in blocking buffer) for overnight in 
fridge. Cells were then washed three times in PBST before incubated in a cocktail of Alexa 
Fluor-conjugated secondary antibodies against chicken (AF633), and rabbit (AF405) (all diluted 
1:200 in blocking buffer) for 1 hour at room temperature. Coverslips were then inversely 
mounted onto glass SuperFrost Plus 76x26mm glass slides (VWR International) containing two 
drops of Vectashield hardset mounting medium (Vectorlabs). Leica SP5 Upright (Laser 
wavelengths used: 405 nm, 514 nm, and 633 nm) was used to visualize the cells. Leica LAS AF 
software was used to obtain the fluorescent micrographs.  
 
Flow cytometry 
Two days after transfection, HEK293T cells were detached from the bottom of the wells with 
accutase (PAA) and washed once in PBS and blocked in blocking buffer (5% BSA in PBS) for 
30 min at room temperature. Cells were stained with 10 µg/ml anti-FLAG antibody or mouse 
IgG1 isotype control in blocking buffer for O/N in fridge, washed and then incubated with 
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secondary antibody conjugated to Alexa Fluor 488 for 1 hour at room temperature in dark. Cells 
were washed and analyzed on BD Accuri C6 flow cytometer.  
Three days after siRNA transfection, THP-1 macrophages were detached from the bottom 
of the wells with cold 10 mM EDTA in PBS and were washed once in 0.5% BSA in PBS and 
blocked in blocking buffer for 30 min at room temperature. Cells were stained in anti-CD284 
(TLR4) PE (2 µg/ test) or mouse IgG2a Κ isotype control PE (0.5 µg/ test) in blocking buffer for 
O/N in the fridge. Cells were washed twice and analyzed on BD Accuri C6 flow cytometer. 
 
Statistical analysis 
All graphs were generated using Prism5 (GraphPad) and the statistical analyses were performed 
using unpaired, two-tailed t test with Welch’s correction to obtain the p-values where 
appropriate.  
 
REFERENCES AND NOTES 
 
1.  C. E. Bryant, D. R. Spring, M. Gangloff, N. J. Gay, The molecular basis of the host 
response to lipopolysaccharide. Nat. Rev. Microbiol. 8, 8 (2010). 
2. J. C. Kagan, T. Su, T. Horng, A. Chow, S. Akira, R. Medzhitov, TRAM couples 
endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 
361 (2008). 
3. J. C. Kagan, R. Medzhitov, Phosphoinositide-mediated adaptor recruitment controls Toll-
like receptor signaling. Cell 125, 943 (2006). 
4. I. Zanoni, R. Ostuni, L. R. Marek, S. Barresi, R. Barbalat, G. M. Barton, F. Granucci, J. 
C. Kagan, CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147, 
868 (2011). 
5. H. Husebye, M. H. Aune, J. Stenvik, E. Samstad, F. Skjeldal, O. Halaas, N. J. Nilsen, H. 
Stenmark, E. Latz, E. Lien, T. E. Mollnes, O. Bakke, T. Espevik, The Rab11a GTPase 
controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on 
phagosomes. Immunity 33, 583 (2010). 
6.  H. Husebye, O. Halaas, H. Stenmark, G. Tunheim, O. Sandanger, B. Bogen, A. Brech, E. 
Latz, T. Espevik, Endocytic pathways regulate Toll-like receptor 4 signaling and link 
innate and adaptive immunity. EMBO J. 25, 683 (2006). 
7. L. A. O'Neill, A. G. Bowie, The family of five: TIR-domain-containing adaptors in Toll-
like receptor signalling. Nat. Rev. Immunol. 7, 353 (2007). 
8. K. Takahashi, T. Shibata, S. Akashi-Takamura, T. Kiyokawa, Y. Wakabayashi, N. 
Tanimura, T. Kobayashi, F. Matsumoto, R. Fukui, T. Kouro, Y. Nagai, K. Takatsu, S. 
Saitoh, K. Miyake, A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is 
required for TLR-dependent immune responses. J. Exp. Med. 204, 2963 (2007). 
9. Y. Wakabayashi, M. Kobayashi, S. Akashi-Takamura, N. Tanimura, K. Konno, K. 
Takahashi, T. Ishii, T. Mizutani, H. Iba, T. Kouro, S. Takaki, K. Takatsu, Y. Oda, Y. 
 20 
Ishihama, S. Saitoh, K. Miyake, A protein associated with toll-like receptor 4 (PRAT4A) 
regulates cell surface expression of TLR4. J. Immunol. 177, 1772 (2006). 
10. F. Randow, B. Seed, Endoplasmic reticulum chaperone gp96 is required for innate 
immunity but not cell viability. Nat. Cell. Biol. 3, 891 (2001). 
11. Y. Nagai, S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. 
Kosugi, M. Kimoto, K. Miyake, Essential role of MD-2 in LPS responsiveness and TLR4 
distribution. Nat. Immunol. 3, 667 (2002). 
12.  J. da Silva Correia, R. J. Ulevitch, MD-2 and TLR4 N-linked glycosylations are 
important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277, 1845 (2002). 
13. T. Ohnishi, M. Muroi, K. Tanamoto, MD-2 is necessary for the toll-like receptor 4 
protein to undergo glycosylation essential for its translocation to the cell surface. Clin. 
Diagn. Lab. Immunol. 10, 405 (2003). 
14. T. L. Gioannini, A. Teghanemt, D. S. Zhang, N. P. Coussens, W. Dockstader, S. 
Ramaswamy, J. P. Weiss, Isolation of an endotoxin-MD-2 complex that produces Toll-
like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. 
Sci. U S A 101, 4186 (2004). 
15. D. Wang, J. Lou, C. Ouyang, W. Chen, Y. Liu, X. Liu, X. Cao, J. Wang, L. Lu, Ras-
related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 
onto the plasma membrane. Proc. Natl. Acad. Sci. U S A 107, 13806 (2010). 
16. F. Brandizzi, C. Barlowe, Organization of the ER-Golgi interface for membrane traffic 
control. Nature Rev. Mol. Cell Biol. 14, 382 (2013). 
17. K. Fiedler, M. Veit, M. A. Stamnes, J. E. Rothman, Bimodal interaction of coatomer with 
the p24 family of putative cargo receptors. Science 273, 1396 (1996). 
18. F. Kappeler, D. R. Klopfenstein, M. Foguet, J. P. Paccaud, H. P. Hauri, The recycling of 
ERGIC-53 in the early secretory pathway. ERGIC-53 carries a cytosolic endoplasmic 
reticulum-exit determinant interacting with COPII. J. Biol. Chem. 272, 31801 (1997). 
19. M. Dominguez, K. Dejgaard, J. Fullekrug, S. Dahan, A. Fazel, J. P. Paccaud, D. Y. 
Thomas, J. J. M. Bergeron, T. Nilsson, gp25L/emp24/p24 protein family members of the 
cis-Golgi network bind both COP I and II coatomer. J. Cell Biol. 140, 751 (1998). 
20. J. Dancourt, C. Barlowe, Protein Sorting Receptors in the Early Secretory Pathway. 
Annu. Rev. Biochem. 79, 777 (2010). 
21. J. R. Strating, N. H. van Bakel, J. A. Leunissen, G. J. Martens, A comprehensive 
overview of the vertebrate p24 family: identification of a novel tissue-specifically 
expressed member. Mol. Biol. Evol. 26, 1707 (2009). 
22. J. R. Strating, G. J. Martens, The p24 family and selective transport processes at the ER-
Golgi interface. Biol. Cell. 101, 495 (2009). 
23. K. Sohn, L. Orci, M. Ravazzola, M. Amherdt, M. Bremser, F. Lottspeich, K. Fiedler, J. 
B. Helms, F. T. Wieland, A major transmembrane protein of Golgi-derived COPI-coated 
vesicles involved in coatomer binding. J. Cell. Biol. 135, 1239 (1996). 
24. J. Fullekrug, T. Suganuma, B. L. Tang, W. J. Hong, B. Storrie, T. Nilsson, Localization 
and recycling of gp27 (hp24 gamma(3)): Complex formation with other p24 family 
members. Mol. Biol. Cell 10, 1939 (1999). 
25. G. Emery, M. Rojo, J. Gruenberg, Coupled transport of p24 family members. J. Cell Sci. 
113, 2507 (2000). 
26. N. Jenne, K. Frey, B. Brugger, F. T. Wieland, Oligomeric state and stoichiometry of p24 
proteins in the early secretory pathway. J. Biol. Chem. 277, 46504 (2002). 
 21 
27. M. A. Stamnes, M. W. Craighead, M. H. Hoe, N. Lampen, S. Geromanos, P. Tempst, J. 
E. Rothman, An integral membrane component of coatomer-coated transport vesicles 
defines a family of proteins involved in budding. Proc. Natl. Acad. Sci. U S A 92, 8011 
(1995). 
28. M. Marzioch, D. C. Henthorn, J. M. Herrmann, R. Wilson, D. Y. Thomas, J. J. Bergeron, 
R. C. Solari, A. Rowley, Erp1p and Erp2p, partners for Emp24p and Erv25p in a yeast 
p24 complex. Mol. Biol. Cell 10, 1923 (1999). 
29. W. J. Belden, C. Barlowe, Deletion of yeast p24 genes activates the unfolded protein 
response. Mol. Biol. Cell 12, 957 (2001). 
30. A. Denzel, F. Otto, A. Girod, R. Pepperkok, R. Watson, I. Rosewell, J. J. M. Bergeron, R. 
C. E. Solari, M. J. Owen, The p24 family member p23 is required for early embryonic 
development. Curr. Biol. 10, 55 (2000). 
31. L. A. Jerome-Majewska, T. Achkar, L. Luo, F. Lupu, E. Lacy, The trafficking protein 
Tmed2/p24beta(1) is required for morphogenesis of the mouse embryo and placenta. 
Dev. Biol. 341, 154 (2010). 
32. S. L. Doyle, H. Husebye, D. J. Connolly, T. Espevik, L. A. J. O'Neill, A. F. McGettrick, 
The GOLD domain-containing protein TMED7 inhibits TLR4 signalling from the 
endosome upon LPS stimulation. Nat. Commun. 3, 707 (2012). 
33. K. Fiedler, J. E. Rothman, Sorting determinants in the transmembrane domain of p24 
proteins. J. Biol. Chem. 272, 24739 (1997). 
34. M. W. Hornef, B. H. Normark, A. Vandewalle, S. Normark, Intracellular recognition of 
lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 198, 
1225 (2003). 
35. E. Latz, A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks, E. A. Kurt-Jones, D. T. 
Golenbock, T. Espevik, Lipopolysaccharide rapidly traffics to and from the Golgi 
apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct 
from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843 (2002). 
36. F. Rocuts, Y. Ma, X. Zhang, W. Gao, Y. Yue, T. Vartanian, H. Wang, Carbon monoxide 
suppresses membrane expression of TLR4 via myeloid differentiation factor-2 in 
betaTC3 cells. J. Immunol. 185, 2134-2139 (2010). 
37. E. M. Palsson-McDermott, S. L. Doyle, A. F. McGettrick, M. Hardy, H. Husebye, K. 
Banahan, M. Gong, D. Golenbock, T. Espevik, L. A. O'Neill, TAG, a splice variant of the 
adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. 
Nat. Immunol. 10, 579-586 (2009). 
38. D. C. Rowe, A. F. McGettrick, E. Latz, B. G. Monks, N. J. Gay, M. Yamamoto, S. Akira, 
A. O'Neill L, K. A. Fitzgerald, D. T. Golenbock, The myristoylation of TRIF-related 
adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. 
Acad. Sci. U S A 103, 6299-6304 (2006). 
39. D. R. Johnson, R. S. Bhatnagar, L. J. Knoll, J. I. Gordon, Genetic and biochemical 
studies of protein N-myristoylation. Annu. Rev. Biochem. 63, 869 (1994). 
40. G. Panter, R. Jerala, The ectodomain of the Toll-like receptor 4 prevents constitutive 
receptor activation. J. Biol. Chem. 286, 23334 (2011). 
41. A. N. Weber, M. A. Morse, N. J. Gay, Four N-linked glycosylation sites in human toll 
like receptor 2 cooperate to direct efficient biosynthesis and secretion. J. Biol. Chem. 279, 
34589-34594 (2004). 
 22 
42. M. Fujita, R. Watanabe, N. Jaensch, M. Romanova-Michaelides, T. Satoh, M. Kato, H. 
Riezman, Y. Yamaguchi, Y. Maeda, T. Kinoshita, Sorting of GPI-anchored proteins into 
ER exit sites by p24 proteins is dependent on remodeled GPI. J. Cell Biol. 194, 61 
(2011). 
43. G. Rudenko, L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, J. 
Deisenhofer, Structure of the LDL receptor extracellular domain at endosomal pH. 
Science 298, 2353-2358 (2002).  
44. W. Luo, Y. Wang, G. Reiser, p24A, a type I transmembrane protein, controls ARF1-
dependent resensitization of protease-activated receptor-2 by influence on receptor 
trafficking. J. Biol. Chem. 282, 30246 (2007). 
45. M. Yoneyama, W. Suhara, Y. Fukuhara, M. Sato, K. Ozato, T. Fujita, Autocrine 
amplification of type I interferon gene expression mediated by interferon stimulated gene 
factor 3 (ISGF3). J. Biochem. 120, 160 (1996). 
46.  A. Reynolds, D. Leake, Q. Boese, S. Scaringe, W. S. Marshall, A. Khvorova, Rational 
siRNA design for RNA interference. Nat. Biotechnol. 22, 326 (2004). 
47. C. Walsh, M. Gangloff, T. Monie, T. Smyth, B. Wei, T. J. McKinley, D. Maskell, N. 
Gay, C. Bryant, Elucidation of the MD-2/TLR4 interface required for signaling by lipid 
IVa. J. Immunol. 181, 1245 (2008). 
48. M. Lewis, C. J. Arnot, H. Beeston, A. McCoy, A. E. Ashcroft, N. J. Gay, M. Gangloff, 
Cytokine Spatzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like 
specificity and couples receptor activation. Proc. Natl. Acad. Sci. U S A 110, 20461 
(2013). 
49. A. N. Weber, M. Gangloff, M. C. Moncrieffe, Y. Hyvert, J. L. Imler, N. J. Gay, Role of 
the Spatzle Pro-domain in the generation of an active toll receptor ligand. J. Biol. Chem. 
282, 13522 (2007). 
50. G. Emery, J. Gruenberg, M. Rojo, The p24 family of transmembrane proteins at the 
interface between endoplasmic reticulum and Golgi apparatus. Protoplasma 207, 24 
(1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures and Tables 
 
 
Figure 1. Characterization of TMED7 protein organization.  (A) Summary of domain arrangement of TMED7, 
based on various prediction tools and previous studies (19, 24, 44, 50) with their residue position numbers indicated 
in the domain boxes. Cysteine 48 and 109 are absolutely conserved in all members of the p24 family across all 
species studied whereas the other cysteine residues are highly conserved (22). Asparagine 103 is predicted to be a 
site of N-glycosylation. Glutamate 193 and glutamine 204 are sorting signals within the transmembrane domain that 
modulate the vesicular trafficking activity of TMED7 (33). Di-phenylalanine residues in the cytoplasmic tail is a 
motif involved in COP II binding (19). (B) TMED7-HA was transiently transfected in HEK293T cells. The whole 
cell lysate was collected and was analyzed for TMED7 glycosylation state by PNGaseF treatment, and for the 
presence of any disulfide bridges by treatment with reducing agent DTT. Western blot was performed using anti-HA 
antibody.  Data is representative of N=2. (C) Cartoon representation of domain organization and topology of 
TMED7 with its N-terminal GOLD domain located within the lumen.  
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Figure 2. Oligomerization of TMED7 is crucial for interaction with TLR4. (A) Constructs of full length 
TMED7 and its truncated mutants (Delta, CC, and GOLD) with C-terminal tag used in this study. SP: signal peptide; 
GOLD: Golgi dynamics domain; L: linker; CC: coiled-coil domain; TM: transmembrane domain; C: cytoplasmic 
tail. (B) TMED7 and its truncated mutants were tested for oligomerization in co-immunoprecipitation (co-IP) assay. 
HEK293T cells were transiently transfected with plasmids as indicated in the panel and the whole cell lysate was 
incubated with anti-FLAG M2 magnetic beads to immunoprecipitate FLAG-tagged recombinant proteins, and anti-
HA antibody was used to detect the interacting HA-tagged protein. Anti-FLAG antibody was used to detect the 
presence of the immunoprecipitated bait, and GAPDH was detected as a loading control. (C) TMED7 and its 
truncated mutants were tested for interaction with TLR4 receptor complex (FLAG-TLR4, MD2, CD14, and TRAM-
FLAG) with 100 ng/ml LPS stimulation for 30 min. (D) TMED7 lacking cytoplasmic tail (Delta) is still capable of 
forming an oligomer with full length TMED7 and interacting with TLR4. Data are representative of N=3. 
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Figure 3. TLR4 and TMED7 co-localization in HEK293T cells without LPS stimulation. Cells were transiently 
transfected with TMED7-HA, TLR4-Citrine, MD2, CD14, and TRAM. 48 hours post-transfection cells were 
permeabilized and TMED7-HA was labelled with AlexaFluor633 (red), and Giantin was detected with 
AlexaFluor405 (blue). Data is representative of two independent experiments where around 20 cells from each 
experiment were observed to have similar pattern.  
 
 
 26 
 
Figure 4. TMED7 knockdown in THP-1 macrophages reduced expression of IL-6 and TNFα cytokines upon 
LPS stimulation. (A) Determination of endogenous gene expression of TMED7 in HEK293T and THP-1 
macrophages by RT-PCR. Total RNA was purified and the cDNA was synthesized by reverse transcription. The 
cDNA was used as template for PCR analysis using gene specific primers. (B) Efficiency of various siRNA 
duplexes targeting TMED7 in HEK293T (top) and THP-1 macrophages (bottom) were measured by qPCR 3 days 
post siRNA transfection. TMED7 gene expression level is normalised against GAPDH or β-Actin and shown as 
relative expression to wild type (WT). (C) Cytokine measurement by ELISA of TNFα (top), IL-6 (middle) and 
RANTES (bottom) produced by THP-1 macrophages. Upon differentiation to THP-1 macrophages, cells were 
transfected with various siRNA duplexes and incubated for three days. Cells were then stimulated with 100 ng/ml 
LPS for 24 hours prior to cytokine measurement by ELISA. Data are from one representative experiment of N=3, 
error bars represent standard deviation. 
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Figure 5. Figure 4. TMED7 regulates TLR4 signalling pre-LPS stimulation. (A) TLR4 on its own is sufficient 
to interact with TMED7. HEK293T cells were transiently transfected with plasmids as indicated in the panel. 
Without LPS stimulation, the whole cell lysate was incubated with anti-FLAG M2 magnetic beads to 
immunoprecipitate FLAG-tagged recombinant proteins, and anti-HA antibody was used to detect the interacting 
HA-tagged protein. Anti-FLAG antibody was used to detect the presence of the immunoprecipitated bait, and 
GAPDH was detected as a loading control. Figure is representative of N=3. (B and C) TMED7’s role on TLR4 
signalling was investigated using reporter luciferase assay in constituted HEK293 cells. TMED7-HA overexpression 
increased the basal level of TLR4 activations of (B) NF-κB and (C) IFN-β in the absence of LPS, but LPS-
stimulated activation of TLR4 remained unaffected. Data is presented as firefly luciferase activity normalized 
against Renilla luciferase activity on Y-axis, and the amount of TMED7 in ng transfected per 10 wells of 96-well 
plate on X-axis. Data is from a representative experiment of N=5. Error bars represent standard deviation.  
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Figure 6. Roles of the transmembrane and cytosolic tail of TMED7 in TLR4 signalling. Loss of the cytoplasmic 
tail of TMED7 (Delta) caused a drastic increase in both NF-κB, and IFNβ activations even at LPS-stimulated state 
(A and B), whereas CC behaved similarly to full length TMED7 (C and D). Data is presented as firefly luciferase 
activity normalized against Renilla luciferase activity on Y-axis, and the amount of Delta-HA or CC-HA plasmid in 
ng transfected per 10 wells of 96-well plate on X-axis. Data is from a representative experiment of N=5. Error bars 
represent standard deviation. 
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Figure 7. Localization of TMED7 in the Golgi in THP-1 macrophages is due to the COP II-binding motif. THP-1 
macrophages were transduced with lentivirus and incubated for three days. The cells were permeabilized and HA-tagged 
TMED7, Delta, CC and GOLD were labelled with AlexaFluor633 (red) whereas endogenous Giantin was labelled with 
AlexaFluor404 (blue). The presence of the di-phenylalanine residues in the cytosolic tail of TMED7 determine its 
localization in the Golgi together with Giantin (A). Loss of the motif leads to loss of distinct localization of TMED7 in 
the Golgi (B, C, and D). Data is representative of two independent experiments where around 20 cells from each 
experiment were observed to have similar pattern. 
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Figure 8. TMED7 enhances cell surface expression of TLR4. Flow cytometric analysis cell surface expression of 
transfected TLR4 in HEK293T cell and endogenous TLR4 in THP-1 macrophages. (A) TMED7 overexpression 
increases FLAG-TLR4 expression on HEK293T cell surface. Histogram shows the shift upon TMED7-HA 
overexpression (compare red and black lines), bottom panel represents the increase in median fluorescence intensity 
(MFI) of cell surface TLR4 staining relative to no overexpression. (B)  TMED7 knock-down in HEK293T cells 
decreases cell surface expression of transfected FLAG-TLR4 (compare red and black lines). Bottom panel shows 
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percentage of TLR4 labelling after the siRNA treatment, cell population stained by isotype control antibody was set 
as the basal level in the quadrant gating. (C and D) TMED7 knock-down in THP-1 macrophages decreases cell 
surface endogenous TLR4 but not the total amount of TLR4. (D) Relative gene expression of TLR4 after 3-day 
siRNA treatment determined by qPCR. Histogram data are representative N=3. MFI, %labelling, and relative gene 
expression data are averaged results from three independent experiments error bars represent standard error of mean, 
p-values were calculated using unpaired, two-tailed t test with Welch’s correction. 
 
 
